Riskpilot← Back to searchSign inGet full accessOssano Scandinavia Oy Ab
OYActiveY-tunnus 0734770-1Länsitie 349Wholesale of pharmaceutical and medical goods · NACE 4646Est. 19894 employees
Revenue 2025
EUR 2,2M
-4% vs 2024
EBITDA margin
19.2%
0% vs 2024
Equity ratio
92.9%
Financial strength
Net profit 2025
EUR 339K
+1% vs 2024
| Revenue | EUR 2,2M | -4% |
| EBITDA | EUR 423K | +0% |
| Net profit | EUR 339K | +1% |
| Total assets | EUR 2M | +11% |
| Equity | EUR 1,9M | +12% |
| Employees | 4 | — |
Legal name
Ossano Scandinavia Oy Ab
Y-tunnus number
0734770-1
Legal form
Osakeyhtiö
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
20. maaliskuuta 1989
Share capital
EUR 3 364
Employees
4 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin ja hallituksen jäsenet kaksi yhdessä
Company purpose
Föremål för bolagets verksamhet är att idka handel med konsumtionsvaror inom sjukvårdsbranschen såsom inplantat och hjälpmedel för rehabilitering.
Address
Länsitie 349
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1 922 | 2 168 | 2 120 | 2 281 | 2 198 |
| Staff expenses | −254 | −280 | −267 | −268 | −289 |
| EBITDA | 378 | 398 | 440 | 422 | 423 |
| Depreciation & amort. | −10 | −9 | −6 | −5 | −4 |
| EBIT | 368 | 390 | 434 | 417 | 419 |
| Net financials | −1 | −1 | −0 | 2 | 4 |
| Profit before tax | 367 | 389 | 433 | 419 | 422 |
| Tax | 74 | 78 | 88 | 84 | 83 |
| Net profit | 294 | 311 | 345 | 335 | 339 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 1 164 | 1 589 | 1 654 | 1 827 | 2 033 |
| Equity | 988 | 1 220 | 1 468 | 1 685 | 1 889 |
| Long-term debt | 30 | 25 | 0 | 0 | 0 |
| Short-term debt | 147 | 343 | 187 | 142 | 144 |
| Total debt | 176 | 368 | 187 | 142 | 144 |
EBITDA margin
19.2%
This company
15.8%
Market median
+22% vs market
20212025
Equity ratio
92.9%
This company
38.2%
Market median
+143% vs market
20212025
Return on equity
17.9%
This company
18.4%
Market median
+3% vs market
20212025
Net profit margin
15.4%
This company
8.1%
Market median
+90% vs market
20212025
Asset turnover
1.08×
This company
1.12×
Market median
+4% vs market
20212025
Debt / equity
0.08×
This company
0.62×
Market median
+87% vs market
20212025
- Annual report 2025Filed via PRH / YTJ · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
TE Deputy auditor | Deputy auditor | 2020 |
SA Chief Executive Officer | Chief Executive Officer | 2018 |
SR | Audit | 2020 |
| Former (2) | ||
MK Deputy auditor | Deputy auditor | 2001 – 2020 |
LJ | Audit | 2001 – 2020 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairperson | 2018 | |
| Board of Directors | 2018 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Ossano Scandinavia Oy Ab also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Tony Erik Hämäläinen | Deputy auditor | 0 companies |
| Sanna-Marika Ala-Luhtala | Chief Executive Officer | 0 companies |
| Stefan Rolf Axel Wiklund | Audit | 0 companies |
| Markku Kalevi Lehto | Deputy auditor | 0 companies |
| Lars-Erik Johan Hanner | Audit | 0 companies |
| Jani Antti Juhana Ala-Luhtala | Chairperson | 0 companies |
| Katja-Johanna Järviö | Board of Directors | 0 companies |